Meeting
2017 ASCO Annual Meeting
Association of baseline plasma levels of 25OH vitamin D and breast cancer risk in a chemoprevention trial.
Authors
Bernardo Bonanni
European Institute of Oncology, Milan, Italy
Bernardo Bonanni , Davide Serrano , Sara Gandini , Harriet Ann Johansson , Debora Macis , Valentina Aristarco , Aliana Guerrieri-Gonzaga , Andrea De Censi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 35, 2017 (suppl; abstr 1546)
DOI
10.1200/JCO.2017.35.15_suppl.1546
Abstract #
1546
Poster Bd #
204
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Use of a SNP panel to refine risk estimates in women at high risk of breast cancer: Results from two randomized tamoxifen prevention trials.
First Author: Jack M. Cuzick
Poster
2014 ASCO Annual Meeting
Patient-reported outcomes and behavioral risk factors as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP) Breast Cancer Prevention P-1 trial.
First Author: Stephanie R. Land
Poster
2014 ASCO Annual Meeting
Relation of genes in estrogen and vitamin D signaling to bone mineral density loss in aromatase inhibitors treatment.
First Author: Sonia Servitja
Poster
2023 ASCO Annual Meeting
A randomized phase 2 non-inferiority trial of (Z)-endoxifen and exemestane + goserelin as neoadjuvant treatment for premenopausal women with ER+/HER2- breast cancer (EVANGELINE).
First Author: Matthew P. Goetz